Dennis J. Donohoe

发表

Postmarket evaluation of breakthrough technologies.

Mitchell W Krucoff, Carl J Pepine, Robert M Califf, 2008, American heart journal.

Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).

W. Wijns, J. Ormiston, H. Bezerra, 2013, The American journal of cardiology.

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.

P. Serruys, A. J. O’Malley, M. Morice, 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).

Antonio Colombo, Patrick W Serruys, Thierry Lefèvre, 2007, European heart journal.

Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents

G. Breithardt, P. Teirstein, A. J. O’Malley, 2005, Circulation.

Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents

G. Dangas, J. Moses, M. Leon, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial).

P. Teirstein, J. Moses, M. Leon, 2002, The American journal of cardiology.

Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.

G. Stone, G. Dangas, J. Moses, 2006, Journal of the American College of Cardiology.

Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial

L. Mauri, M. Jaff, J. Popma, 2015, Circulation. Cardiovascular interventions.

The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results.

M. Jaff, J. Popma, A. Feiring, 2004, Journal of vascular and interventional radiology : JVIR.

Carotid artery stenting with emboli protection surveillance study: Thirty‐day results of the CASES‐PMS study

L. Mauri, B. Katzen, Sidney A. Cohen, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial.

A. Lansky, W. Wijns, M. Vrolix, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

R. Whitbourn, P. Fitzgerald, A. Lansky, 2013, JACC. Cardiovascular interventions.

Adventitial Drug Delivery of Dexamethasone to Improve Primary Patency in the Treatment of Superficial Femoral and Popliteal Artery Disease: 12-Month Results From the DANCE Clinical Trial.

R. D'Agostino, M. Jaff, M. Razavi, 2018, JACC. Cardiovascular interventions.

Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.

Hong Wang, J. Moses, M. Leon, 2006, Journal of the American College of Cardiology.

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I.

P. Serruys, K. Kuck, H. Garcia-Garcia, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials.

P. Stella, M. Morice, W. Wijns, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?

R. D. de Winter, J. Wykrzykowska, K. Koch, 2017, Expert review of medical devices.

Bioabsorbable polymer‐coated sirolimus‐eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub‐study

W. Desmet, C. Di Mario, A. Lansky, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.

G. Breithardt, Hong Wang, J. Moses, 2006, The American journal of cardiology.

Carotid artery stenting with emboli protection surveillance study: outcomes at 1 year.

G. Mishkel, M. Foster, V. Kumar, 2010, Journal of the American College of Cardiology.

Bioabsorbable polymer‐coated sirolimus‐eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub‐study

W. Desmet, A. Lansky, W. Wijns, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

R. Whitbourn, P. Fitzgerald, A. Lansky, 2013, JACC. Cardiovascular interventions.

Drug-Eluting Stents in the Treatment of Intermediate Lesions

G. Stone, G. Dangas, G. Weisz, 2006 .

Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial).

W. Wijns, J. Ormiston, H. Bezerra, 2013, The American journal of cardiology.